Malecare

Malecare and the New York State Prostate Cancer Coalition Are Victorious and Force the Hand of New York State Governor Andrew Cuomo to Fund $3,000,000 Towards Prostate Cancer Research

Approximately 2 years ago Malecare and the New York State Prostate Coalition began asking questions about where the State of New York was hiding approximately $3,000,000 in funding for prostate cancer research. Each year New York State residents are asked to check off a little box on their state tax return donating an additional dollar [...]

By Malecare|2017-10-19T10:46:55-04:00October 8th, 2015|Advanced Prostate Cancer, Advocacy, Clinical Trials & Research, Financial, Politics of Cancer, Research, Uncategorized|0 Comments

Chemotherapy After Radium-223 Appears to be Safe in Men with Metastatic Castration-Resistant Prostate Cancer

Understanding how to best sequence and combine our new drugs to treat advanced prostate cancer includes the most discussed issue, efficacy. We want to know if a special order or a special combination of the approved drugs will nake a difference in both our quality of life (QoL) as well as how survival. Often [...]

By Malecare|2015-09-30T10:21:06-04:00September 30th, 2015|Advanced Prostate Cancer, Chemotherapy, Combination Therapy, Drugs & Treatments, radiopharmaceuticals, Research, Survival, Uncategorized, Understanding Advanced Prostate Cancer, Xofigo|0 Comments

Abiraterone Is Effective In Men Over 75 Years Who Are Chemotherapy-Naive And Have mCRPC

We know that Abiraterone (Zytiga) extends life, but we also know that its side effects can be harsh, especially in elderly men (men over 75 years). We also know that men with metastatic, castrate resistant prostate cancer (mCRPC) have a limited potential life expectancy. Given these facts, it is important to know if, despite being [...]

By Malecare|2017-10-19T10:46:55-04:00September 29th, 2015|abiraterone acetate, Advanced Prostate Cancer, Drugs & Treatments, Research, Uncategorized, Understanding Advanced Prostate Cancer, Zytiga|0 Comments

Understanding and Trying to Rectify the Abusive Costs of Our Drugs

I have been relatively quiet about the skyrocketing cost of drugs, but it has now become impossible to remain out of the fray. A Pharmaceutical company recently acquired a drug called Daraprim, the drug treats potentially fatal parasitic infections. After its acquisition the company raised the price of Daraprim by almost 5,0000%. When confronted with [...]

By Malecare|2017-10-19T10:46:55-04:00September 28th, 2015|Advanced Prostate Cancer, Advocacy, Drugs & Treatments, Financial, Insurance, Medical Insurance, Medicare/Medicaid, Politics of Cancer, Survival, Uncategorized|0 Comments

Radium-223 When Given In Combinations May Improve Survival in mCRPC

As I have said before, the next big step in the clinical care of men with prostate cancer will be in not in the development of a new drug, but in our growing knowledge of how to sequence and combine our new drugs. Today’s post provides just one example of this new type of breakthrough [...]